Patents by Inventor Hamed Tabatabaei Ghomi

Hamed Tabatabaei Ghomi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMERASES, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20230357731
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain high fidelity under reduced incorporation times, as well as methods and kits using the same.
    Type: Application
    Filed: March 13, 2023
    Publication date: November 9, 2023
    Applicants: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED, ILLUMINA SINGAPORE PTE. LTD.
    Inventors: Kay Klausing, Hamed Tabatabaei Ghomi, Misha Golynskiy, Saurabh Nirantar, Seth McDonald, Sergio Peisajovich
  • Polymerases, compositions, and methods of use
    Patent number: 11634697
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain high fidelity under reduced incorporation times, as well as methods and kits using the same.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: April 25, 2023
    Assignees: Illumina, Inc., Illumina Cambridge Limited, Illumina Singapore Pte. Ltd.
    Inventors: Kay Klausing, Hamed Tabatabaei Ghomi, Misha Golynskiy, Saurabh Nirantar, Seth McDonald, Sergio Peisajovich
  • POLYMERASES, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20230047225
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain low pre-phasing rates when using ambiently stored polymerases, as well as methods and kits using the same.
    Type: Application
    Filed: June 1, 2022
    Publication date: February 16, 2023
    Applicants: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED, ILLUMINA SINGAPORE PTE. LTD.
    Inventors: Misha Golynskiy, Mariko Matsuura, Saurabh Nirantar, Hamed Tabatabaei Ghomi, Seth McDonald, Ryan Craig, Sergio Peisajovich, Kyrie Johnson, Kay Klausing, Eric Murtfeldt, Alexandra Exner
  • Modified glucagon molecules
    Patent number: 11472857
    Abstract: The invention generally relates to modified glucagon molecules. In certain embodiments, the invention provides a glucagon molecule that includes one or more modified amino acids to result in the glucagon molecule being soluble at a substantially neutral pH and resistant to fibrillation. Modifications may include, for example, phosphorylation or sulfation.
    Type: Grant
    Filed: February 17, 2021
    Date of Patent: October 18, 2022
    Assignee: Purdue Research Foundation
    Inventors: Elizabeth M. Murphy Topp, Hamed Tabatabaei Ghomi, Markus Lill, Shenbaga Moorthy Balakrishnan
  • POLYMERASES, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20210348141
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain high fidelity under reduced incorporation times, as well as methods and kits using the same.
    Type: Application
    Filed: April 9, 2021
    Publication date: November 11, 2021
    Applicants: Illumina, Inc., Illumina Cambridge Limited, Illumina Singapore Pte. Ltd.
    Inventors: Kay Klausing, Hamed Tabatabaei Ghomi, Misha Golynskiy, Saurabh Nirantar, Seth McDonald, Sergio Peisajovich
  • MODIFIED GLUCAGON MOLECULES
    Publication number: 20210300982
    Abstract: The invention generally relates to modified glucagon molecules. In certain embodiments, the invention provides a glucagon molecule that includes one or more modified amino acids to result in the glucagon molecule being soluble at a substantially neutral pH and resistant to fibrillation. Modifications may include, for example, phosphorylation or sulfation.
    Type: Application
    Filed: February 17, 2021
    Publication date: September 30, 2021
    Inventors: Elizabeth M. Murphy Topp, Hamed Tabatabaei Ghomi, Markus Lill, Shenbaga Moorthy Balakrishnan
  • Polymerases, compositions, and methods of use
    Patent number: 11001816
    Abstract: Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain high fidelity under reduced incorporation times, as well as methods and kits using the same.
    Type: Grant
    Filed: December 4, 2019
    Date of Patent: May 11, 2021
    Assignees: Illumina, Inc., Illumina Singapore PTE. LTD., Illumina Cambridge Limited
    Inventors: Kay Klausing, Hamed Tabatabaei Ghomi, Misha Golynskiy, Saurabh Nirantar, Seth McDonald, Sergio Peisajovich
  • Modified glucagon molecules
    Patent number: 10954283
    Abstract: The invention generally relates to modified glucagon molecules. In certain embodiments, the invention provides a glucagon molecule that includes one or more modified amino acids to result in the glucagon molecule being soluble at a substantially neutral pH and resistant to fibrillation. Modifications may include, for example, phosphorylation or sulfation.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: March 23, 2021
    Assignee: Purdue Research Foundation
    Inventors: Elizabeth M. Murphy Topp, Hamed Tabatabaei Ghomi, Markus Lill, Shenbaga Moorthy Balakrishnan
  • MODIFIED GLUCAGON MOLECULES
    Publication number: 20190202884
    Abstract: The invention generally relates to modified glucagon molecules. In certain embodiments, the invention provides a glucagon molecule that includes one or more modified amino acids to result in the glucagon molecule being soluble at a substantially neutral pH and resistant to fibrillation.
    Type: Application
    Filed: February 19, 2019
    Publication date: July 4, 2019
    Inventors: Elizabeth M. Murphy Topp, Hamed Tabatabaei Ghomi, Markus Lill, Shenbaga Moorthy Balakrishnan
  • Modified glucagon molecules
    Patent number: 10308701
    Abstract: The invention generally relates to modified glucagon molecules. In certain embodiments, the invention provides a glucagon molecule that includes one or more modified amino acids, e.g., phosphorylation and/or sulfation, to result in the glucagon molecule being soluble at a substantially neutral pH and resistant to fibrillation.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: June 4, 2019
    Assignee: Purdue Research Foundation
    Inventors: Elizabeth M. Murphy Topp, Hamed Tabatabaei Ghomi, Markus Lill, Shenbaga Moorthy Balakrishnan
  • MODIFIED GLUCAGON MOLECULES
    Publication number: 20180298076
    Abstract: The invention generally relates to modified glucagon molecules. In certain embodiments, the invention provides a glucagon molecule that includes one or more modified amino acids to result in the glucagon molecule being soluble at a substantially neutral pH and resistant to fibrillation.
    Type: Application
    Filed: July 22, 2016
    Publication date: October 18, 2018
    Inventors: Elizabeth M. Murphy Topp, Hamed Tabatabaei Ghomi, Markus Lill, Shenbaga Moorthy Balakrishnan